Related Experiment Videos
IV. Uterine fibroid embolization: follow-up
John C Lipman1, Steven J Smith, James B Spies
1Vascular and Interventional Section, Mallinckrodt Institute of Radiology, 510 S Kingshighway Boulevard, St. Louis, MO 63110, USA.
Techniques in Vascular and Interventional Radiology
|July 5, 2002
Summary
Uterine fibroid embolization (UFE) provides symptom relief within weeks, with fibroid shrinkage continuing for up to a year. The degree of shrinkage does not correlate with symptom relief intensity.
Area of Science:
- Interventional Radiology
- Gynecology
- Vascular Surgery
Background:
- Uterine fibroids cause significant symptoms like menorrhagia and mass effect.
- Uterine fibroid embolization (UFE) is an established treatment option.
Purpose of the Study:
- To evaluate the time course of symptom relief and fibroid shrinkage after UFE.
- To correlate fibroid shrinkage with symptom relief and post-procedure outcomes.
Main Methods:
- Analysis of procedural and follow-up data from a nationwide registry.
- Tracking of symptom changes and fibroid size via diagnostic imaging.
Main Results:
- Symptom relief is typically noticed within the first few weeks post-UFE.
- Fibroid shrinkage progresses over several months, peaking between 3-6 months, and can continue up to 1 year.
- The extent of fibroid shrinkage does not correlate with immediate post-procedure symptoms or the degree of symptom relief.
Conclusions:
- UFE offers prompt symptom relief and sustained fibroid shrinkage.
- Fibroid degeneration into softer, acellular material is a key post-embolization change.
- Ongoing data collection is crucial for assessing UFE efficacy, complications, and long-term durability.